Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
BlackDoctor1d
Snack Sales Are Dropping: Is Weight Loss Medication to Blame
The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more ...
Outsourcing-pharma3d
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Pharmaceutical Technology4d
Strong Wegovy revenue growth for Novo Nordisk but shares dip
Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...
Pharmaceutical Technology5d
Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...
Catalent Misses Q1 Revenue Estimates Ahead of $16.5 Billion Deal Close With Novo Holdings
Catalent's revenue for fiscal first quarter ended Sept. 30 was $1.02 billion, marginally below analysts' estimates of $1.06 ...
Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...
KSL16d
Weight loss drugs didn't curb health costs within 2 years, data show
WASHINGTON — Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters. The full-year cost of care for U.S ...